RNASEK and pancreatic adenocarcinoma: Conclusions: In conclusion, this study’s pan-cancer analysis revealed that RNASEK could be a potential diagnostic biomarker in six cancer types, including BLCA, CHOL, ESCA, HNSC, LIHC, and THCA, and as a prognostic biomarker in PAAD.